<DOC>
	<DOCNO>NCT00165074</DOCNO>
	<brief_summary>The purpose study determine whether additional surfactant ( Infasurf ) dose 7 10 day life time improve lung function premature infant , allow decrease require oxygen concentration ventilator setting .</brief_summary>
	<brief_title>Pilot Trial Surfactant Therapy For Preterm Neonates 5-21 Days Old With Respiratory Decompensation</brief_title>
	<detailed_description>Pulmonary surfactant require normal lung function . Preliminary data previous trial suggest half chronically ventilated premature infant , great 1 week age , least one episode surfactant dysfunction , measure vitro , associate low surfactant protein B content . We propose enroll premature infant less 1250 gm birthweight , day 5 21 life intubate , mechanically ventilate , respiratory decompensation , define severity score ( mean airway pressure x FIO2 ) rise baseline &lt; 1.8 &gt; 3.5 , sustain &gt; 24 hour . Infants receive two dos Infasurf surfactant , 12-24 hour apart , standard dose 3 ml/kg . Primary outcome change respiratory severity score 72 hour post surfactant treatment compare pre-treatment . Sample size 31 infant , study duration 3 year , recruitment study patient occur Hospital University Pennsylvania , Women Children 's Hospital Buffalo .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Calfactant</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<criteria>Less 1250 gm birthweight Day 521 life Intubated mechanically ventilate , respiratory decompensation , define majority daily severity score ( calculate every 6 hr average respiratory setting 34 hour period ) rise baseline &lt; 1.8 , &gt; 3.5 , sustain &gt; 24hr . Note : Prior surfactant therapy birth neither inclusion exclusion criterion . Serious congenital malformation Life expectancy &lt; 7 day enrollment Patent ductus arteriosus time decompensation Pulmonary hemorrhage cause respiratory decompensation Active air leak syndrome time decompensation Postnatal steroid therapy lung disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Days</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Prematurity</keyword>
	<keyword>Lung Disease</keyword>
	<keyword>Hyaline Membrane</keyword>
	<keyword>Surfactant</keyword>
</DOC>